Minor triplets and carriers are jointly said to refer to hepatitis B. Minor triple positive refers to a person with hepatitis B. It is a chronic state of infection after the hepatitis B virus has infected a person and is likely to cause liver damage as well as damage to other organs. If a person is a carrier, it means that there is no detectable liver damage, the liver function is normal and the general shape of the liver is normal, and only then can the person be called a carrier. There are currently no treatment options for carriers of small triplets, as the corresponding treatment is generally unable to change the status of small triplet hepatitis B carriers. Only when liver damage occurs in patients with small triplets will the relevant medication be applied, because then there are ways to stop the liver damage from continuing, even if long-term oral antiviral medication is required. In the state of SSP carriers, antiviral drugs can only reduce the viral load, but they are not able to remove the virus completely. Therefore, for those who are carriers of small triplets, antiviral treatment is generally not required, but regular review is needed.